Before a new medicine can be prescribed by doctors, it goes through years of careful testing. Clinical trials happen in steps called phases. Each phase answers different questions, and a medicine must pass each step before moving to the next. Here is a simple guide, based on information from the U.S. Food and Drug Administration (FDA).
Before people: lab and animal studies
Researchers first study a possible medicine in the lab. If early results look promising and reasonably safe, the company or research team asks the FDA for permission to begin testing in people.
Phase 1: Is it safe, and what dose?
- Who takes part: about 20 to 100 people, either healthy volunteers or people with the condition
- How long: several months
- Main goal: learn about safety, side effects and the right dose
According to the FDA, about 70% of drugs move on to the next phase.
Phase 2: Does it work?
- Who takes part: up to several hundred people with the condition
- How long: several months to 2 years
- Main goal: learn whether the medicine works and keep checking for side effects
About 33% of drugs move on to Phase 3.
Phase 3: How does it compare?
- Who takes part: about 300 to 3,000 people with the condition
- How long: 1 to 4 years
- Main goal: confirm whether the medicine works, watch for less common side effects and often compare it with current treatments
About 25% to 30% of drugs move on. After Phase 3, the company may ask the FDA to approve the medicine. FDA experts carefully review all the data before deciding.
Phase 4: After approval
- Who takes part: several thousand people with the condition
- Main goal: keep monitoring safety and effectiveness once the medicine is available to the public
Phase 4 studies can reveal rare side effects or long-term effects that only show up when many more people use a medicine.
Why so many steps?
Each phase builds on what was learned before, and only medicines that show promise move forward. This careful process protects volunteers and helps make sure the medicines your doctor prescribes have been tested thoroughly.
How volunteers are protected in every phase
- An independent review board must approve every study before it starts.
- Every volunteer goes through informed consent and can ask questions at any time.
- Taking part is always voluntary, and you can leave a study whenever you choose.
- Study teams closely monitor participants’ health throughout.
Where research sites fit in
Research sites like Pivotal Research Solutions in Lithonia, GA, work with study sponsors to carry out trials in our community, so local volunteers have the chance to take part in research close to home.
Interested in clinical research?
Pivotal Research Solutions is a clinical research site in Lithonia, GA. If you would like to hear about research studies that may be a fit for you, join our Study Interest List. Joining is free, takes about two minutes and does not sign you up for any study. Questions? Call 678-825-2887 or email contact@pivotalrs.com.
Sources
- U.S. Food and Drug Administration: Step 3, Clinical Research
- National Institutes of Health: NIH Clinical Research Trials and You, The Basics
- U.S. Department of Health and Human Services: Participating in Human Research and Clinical Trials
This article is for general education only and is not medical advice. Talk with your own doctor or health care provider about what is right for you.

